EE200300151A - Anticholinergics used as medicaments and methods for their preparation - Google Patents

Anticholinergics used as medicaments and methods for their preparation

Info

Publication number: EE200300151A
Authority: EE; Estonia
Prior art keywords: medicaments; preparation; methods; anticholinergics used; anticholinergics
Prior art date: 2000-10-14

Application number

EEP200300151A

Other languages

Estonian (et)

Inventor

Meissner Helmut

Morschh�user Gerd

Paul Pieper Michael

Pohl Gerald

Reichl Richard

Speck Georg

Banholzer Rolf

Original Assignee

Boehringer Ingelheim Pharma Gmbh & Co. Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-14

Filing date

2001-09-28

Publication date

2003-06-16

2001-09-28 Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg

2003-06-16 Publication of EE200300151A publication Critical patent/EE200300151A/en

2009-06-15 Publication of EE05179B1 publication Critical patent/EE05179B1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

EEP200300151A 2000-10-14 2001-09-28 Anticholinergics used as medicaments and a process for their preparation EE05179B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10050994A DE10050994A1 (en)	2000-10-14	2000-10-14	New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
PCT/EP2001/011226 WO2002032899A1 (en)	2000-10-14	2001-09-28	Novel anticholinergic agents that can be used as medicaments and method for the production thereof

Publications (2)

Publication Number	Publication Date
EE200300151A true EE200300151A (en)	2003-06-16
EE05179B1 EE05179B1 (en)	2009-06-15

Family

ID=7659808

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300151A EE05179B1 (en)	2000-10-14	2001-09-28	Anticholinergics used as medicaments and a process for their preparation

Country Status (38)

Country	Link
EP (2)	EP1382606A3 (en)
JP (2)	JP4109106B2 (en)
KR (1)	KR100830359B1 (en)
CN (1)	CN1275962C (en)
AR (1)	AR035589A1 (en)
AT (1)	ATE259805T1 (en)
AU (2)	AU2002213975B2 (en)
BG (1)	BG66225B1 (en)
BR (1)	BR0114635A (en)
CA (1)	CA2425557C (en)
DE (2)	DE10050994A1 (en)
DK (1)	DK1325001T3 (en)
EA (1)	EA005816B1 (en)
EC (1)	ECSP034542A (en)
EE (1)	EE05179B1 (en)
ES (1)	ES2215147T3 (en)
HK (1)	HK1060566A1 (en)
HR (1)	HRP20030278B1 (en)
HU (1)	HUP0301203A3 (en)
IL (2)	IL155334A0 (en)
ME (1)	MEP39908A (en)
MX (1)	MXPA03003160A (en)
MY (1)	MY127144A (en)
NO (1)	NO328207B1 (en)
NZ (1)	NZ525836A (en)
PE (1)	PE20020433A1 (en)
PL (1)	PL207311B1 (en)
PT (1)	PT1325001E (en)
RS (1)	RS50464B (en)
SA (1)	SA01220414B1 (en)
SI (1)	SI1325001T1 (en)
SK (1)	SK287138B6 (en)
TR (1)	TR200400376T4 (en)
TW (1)	TWI306098B (en)
UA (1)	UA73804C2 (en)
UY (1)	UY26958A1 (en)
WO (1)	WO2002032899A1 (en)
ZA (1)	ZA200302914B (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10200943A1 (en)	2002-01-12	2003-07-24	Boehringer Ingelheim Pharma	Process for the preparation of scopine esters
US7405224B2 (en)	2002-01-31	2008-07-29	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (en) *	2002-01-31	2003-08-14	Boehringer Ingelheim Pharma	New xanthene carboxylic acid esters, processes for their preparation and their use as medicines
US7417051B2 (en)	2002-04-12	2008-08-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments comprising betamimetics and a novel anticholinergic
DE10216429A1 (en) *	2002-04-12	2003-10-23	Boehringer Ingelheim Pharma	Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide
DE10256317A1 (en) *	2002-04-12	2003-10-23	Boehringer Ingelheim Pharma	Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
PT1497289E (en) *	2002-04-12	2005-11-30	Boehringer Ingelheim Pharma	PHARMACO CONTAINING BETAMIMETICS AND A NEW ANTICOLINERGIC
US7084153B2 (en)	2002-04-12	2006-08-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments comprising steroids and a novel anticholinergic
DE10224091A1 (en) *	2002-05-31	2003-12-11	Boehringer Ingelheim Pharma	Technical process for the production of tropenol
DE10230769A1 (en) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug compositions based on new anticholinergics and PDE-IV inhibitors
EP1534282B1 (en) *	2002-07-09	2006-12-27	Boehringer Ingelheim Pharma GmbH & Co.KG	Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
DE10230751A1 (en) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug compositions based on new anticholinergics and EGFR kinase inhibitors
DE10230750A1 (en) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug compositions based on new anticholonergics and NK1 receptor antagonists
CN1674887A (en) *	2002-08-14	2005-09-28	贝林格尔英格海姆法玛两合公司	Aerosol formulation for inhalation comprising an anticholinergic
DE10237739A1 (en) *	2002-08-17	2004-02-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent
US7244742B2 (en)	2002-08-17	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co Kg	Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (en)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
US7332175B2 (en)	2003-05-27	2008-02-19	Boehringer Ingelheim International Gmbh	Long-acting drug combinations for the treatment of respiratory complaints
DE10323966A1 (en) *	2003-05-27	2004-12-16	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New long-acting drug combinations for the treatment of respiratory diseases
DE10331350A1 (en) *	2003-07-11	2005-01-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient
US7462367B2 (en)	2003-07-11	2008-12-09	Boehringer Ingelheim International Gmbh	Anticholinergic powder formulations for inhalation
US7273603B2 (en) *	2003-07-11	2007-09-25	Boehringer Ingelheim International Gmbh	HFC solution formulations containing an anticholinergic
JP2007500148A (en) *	2003-07-28	2007-01-11	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Medicament containing PDEIV inhibitor and novel anticholinergic agent and use of the medicament for treating respiratory diseases
ES2326320T3 (en) *	2003-07-28	2009-10-07	Boehringer Ingelheim International Gmbh	INHALATION DRUGS THAT INCLUDE STEROIDS AND NEW ESTER OF FLUORENCARBOXILIC ACID.
EP1651221B1 (en) *	2003-07-28	2009-01-14	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising betamimetics and an anticholinergic agent
CA2534120C (en) *	2003-07-31	2012-09-11	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising anticholinergics and a betamimetic
EP1504756A1 (en) *	2003-08-06	2005-02-09	Kyowa Hakko Kogyo Co., Ltd	Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (en)	2003-09-26	2005-04-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for inhalation containing an anticholinergic
WO2005067929A1 (en) *	2004-01-09	2005-07-28	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US7507745B2 (en)	2004-02-20	2009-03-24	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
US20050186175A1 (en) *	2004-02-20	2005-08-25	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
EP1718301A1 (en) *	2004-02-20	2006-11-08	Boehringer Ingelheim International GmbH	Pharmaceutical compositions based on anticholinergics and pegsunercept
DE102004016179A1 (en) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Compounds for the treatment of proliferative processes
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (en) *	2004-08-11	2009-06-17	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	MEDICINES CONTAINING ANTI-POLINERGIC FOR TREATMENT IN URINARY ROADS.
DE102004056578A1 (en) *	2004-11-23	2006-05-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Inhaled drugs containing a new anticholinergic, formoterol and a steroid
WO2006087316A1 (en) *	2005-02-16	2006-08-24	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions comprising anticholinergics and etiprednol
WO2006094924A2 (en) *	2005-03-09	2006-09-14	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
CA2609429A1 (en) *	2005-05-31	2006-12-07	Boehringer Ingelheim International Gmbh	Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
JP2008543806A (en) *	2005-06-17	2008-12-04	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	MRPIV inhibitors for the treatment of respiratory diseases
DE102005030733A1 (en)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
PL1917253T3 (en)	2005-08-15	2015-06-30	Boehringer Ingelheim Int	Method for producing betamimetics
EP1948164A1 (en)	2005-10-19	2008-07-30	Ranbaxy Laboratories, Ltd.	Pharmaceutical compositions of muscarinic receptor antagonists
DE102005055957A1 (en) *	2005-11-24	2007-07-12	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for inhalation containing an anticholinergic
DE102005055963A1 (en) *	2005-11-24	2007-07-19	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosol formulation for inhalation containing an anticholinergic
DE102005055961A1 (en) *	2005-11-24	2007-05-31	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical composition containing specific concentration of quaternary ammonium anticholinergic agent, useful for treatment, by inhalation, of respiratory tract diseases
US20090324510A1 (en)	2006-08-07	2009-12-31	Boehringer Ingelheim International Gmbh	Drug combinations for the treatment of respiratory tract diseases
US20080207659A1 (en)	2007-02-15	2008-08-28	Asit Kumar Chakraborti	Inhibitors of phosphodiesterase type 4
MX2009009793A (en)	2007-03-14	2009-10-16	Ranbaxy Lab Ltd	Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors.
ES2569359T3 (en)	2007-07-06	2016-05-10	Vectura Delivery Devices Limited	Inhaler
JP2010533676A (en) *	2007-07-18	2010-10-28	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Novel composition for the treatment of respiratory diseases
EP2077132A1 (en)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispensing device, storage device and method for dispensing a formulation
EP2082771A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082768A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082767A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082772A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Inhaler
EP2082766A1 (en)	2008-01-24	2009-07-29	Vectura Delivery Devices Limited	Blister Strip Coil Forming
EP2111861A1 (en)	2008-04-21	2009-10-28	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type IV inhibitors
US10011906B2 (en)	2009-03-31	2018-07-03	Beohringer Ingelheim International Gmbh	Method for coating a surface of a component
EP3508239B1 (en)	2009-05-18	2020-12-23	Boehringer Ingelheim International GmbH	Adapter, inhalant apparatus and atomizer
GB0918450D0 (en)	2009-10-21	2009-12-09	Innovata Ltd	Composition
UA107097C2 (en)	2009-11-25	2014-11-25	Бьорінгер Інгельхайм Інтернаціональ Гмбх	Dispenser
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
WO2011064163A1 (en)	2009-11-25	2011-06-03	Boehringer Ingelheim International Gmbh	Nebulizer
EP2585151B1 (en)	2010-06-24	2018-04-04	Boehringer Ingelheim International GmbH	Nebulizer
WO2012130757A1 (en)	2011-04-01	2012-10-04	Boehringer Ingelheim International Gmbh	Medical device comprising a container
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013152894A1 (en)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Atomiser with coding means
LT3473255T (en)	2012-12-21	2022-03-10	Boehringer Ingelheim Vetmedica Gmbh	Pharmaceutical formulation comprising ciclesonide
BR112015010842B1 (en)	2012-12-21	2021-03-30	Boehringer Ingelheim Vetmedica Gmbh	USE OF CYCLESONIDE FOR THE TREATMENT OF RESPIRATORY TRACT DISEASE IN HORSES
ES2836977T3 (en)	2013-08-09	2021-06-28	Boehringer Ingelheim Int	Nebulizer
WO2015018904A1 (en)	2013-08-09	2015-02-12	Boehringer Ingelheim International Gmbh	Nebulizer
US10195374B2 (en)	2014-05-07	2019-02-05	Boehringer Ingelheim International Gmbh	Container, nebulizer and use
WO2015169430A1 (en)	2014-05-07	2015-11-12	Boehringer Ingelheim International Gmbh	Nebulizer
KR102492824B1 (en)	2014-05-07	2023-01-30	베링거 인겔하임 인터내셔날 게엠베하	Nebulizer, indicator device and container
DK3157522T3 (en)	2014-06-18	2019-12-09	Boehringer Ingelheim Vetmedica Gmbh	MUSCARIN ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF HORSE DISEASES
WO2017040772A1 (en) *	2015-09-04	2017-03-09	Janssen Pharmaceutica Nv	Therapeutic compounds and synthesis
CN113292574B (en) *	2020-02-21	2022-05-03	四川大学	Chiral polycyclic tropane compounds, preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4003270A1 (en) *	1990-02-03	1991-08-08	Boehringer Ingelheim Kg	NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
DE4108393A1 (en) *	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

2000
- 2000-10-14 DE DE10050994A patent/DE10050994A1/en not_active Withdrawn
2001
- 2001-09-28 JP JP2002536281A patent/JP4109106B2/en not_active Expired - Lifetime
- 2001-09-28 AU AU2002213975A patent/AU2002213975B2/en not_active Expired
- 2001-09-28 EA EA200300459A patent/EA005816B1/en not_active IP Right Cessation
- 2001-09-28 CN CNB018171443A patent/CN1275962C/en not_active Expired - Lifetime
- 2001-09-28 DE DE50101524T patent/DE50101524D1/en not_active Expired - Lifetime
- 2001-09-28 CA CA002425557A patent/CA2425557C/en not_active Expired - Lifetime
- 2001-09-28 AU AU1397502A patent/AU1397502A/en active Pending
- 2001-09-28 AT AT01982374T patent/ATE259805T1/en active
- 2001-09-28 PL PL360673A patent/PL207311B1/en not_active IP Right Cessation
- 2001-09-28 SK SK435-2003A patent/SK287138B6/en not_active IP Right Cessation
- 2001-09-28 KR KR1020037005256A patent/KR100830359B1/en not_active IP Right Cessation
- 2001-09-28 EP EP03023933A patent/EP1382606A3/en not_active Withdrawn
- 2001-09-28 HU HU0301203A patent/HUP0301203A3/en unknown
- 2001-09-28 WO PCT/EP2001/011226 patent/WO2002032899A1/en active IP Right Grant
- 2001-09-28 MX MXPA03003160A patent/MXPA03003160A/en active IP Right Grant
- 2001-09-28 IL IL15533401A patent/IL155334A0/en active IP Right Grant
- 2001-09-28 TR TR2004/00376T patent/TR200400376T4/en unknown
- 2001-09-28 EP EP01982374A patent/EP1325001B1/en not_active Expired - Lifetime
- 2001-09-28 PT PT01982374T patent/PT1325001E/en unknown
- 2001-09-28 RS YUP-295/03A patent/RS50464B/en unknown
- 2001-09-28 ME MEP-399/08A patent/MEP39908A/en unknown
- 2001-09-28 DK DK01982374T patent/DK1325001T3/en active
- 2001-09-28 BR BR0114635-1A patent/BR0114635A/en not_active Expired - Fee Related
- 2001-09-28 UA UA2003054186A patent/UA73804C2/en unknown
- 2001-09-28 EE EEP200300151A patent/EE05179B1/en not_active IP Right Cessation
- 2001-09-28 SI SI200130085T patent/SI1325001T1/en unknown
- 2001-09-28 ES ES01982374T patent/ES2215147T3/en not_active Expired - Lifetime
- 2001-09-28 NZ NZ525836A patent/NZ525836A/en not_active IP Right Cessation
- 2001-10-02 SA SA01220414A patent/SA01220414B1/en unknown
- 2001-10-10 UY UY26958A patent/UY26958A1/en not_active Application Discontinuation
- 2001-10-12 TW TW090125220A patent/TWI306098B/en not_active IP Right Cessation
- 2001-10-12 MY MYPI20014765A patent/MY127144A/en unknown
- 2001-10-12 AR ARP010104785A patent/AR035589A1/en active Pending
- 2001-10-12 PE PE2001001018A patent/PE20020433A1/en not_active Application Discontinuation
2003
- 2003-03-28 BG BG107688A patent/BG66225B1/en active Active
- 2003-04-07 EC EC2003004542A patent/ECSP034542A/en unknown
- 2003-04-10 IL IL155334A patent/IL155334A/en not_active IP Right Cessation
- 2003-04-11 ZA ZA200302914A patent/ZA200302914B/en unknown
- 2003-04-11 HR HR20030278A patent/HRP20030278B1/en not_active IP Right Cessation
- 2003-04-11 NO NO20031693A patent/NO328207B1/en not_active IP Right Cessation
2004
- 2004-05-20 HK HK04103582A patent/HK1060566A1/en not_active IP Right Cessation
2008
- 2008-02-14 JP JP2008033492A patent/JP2008120834A/en active Pending

Also Published As

Publication number	Publication date
PE20020433A1 (en)	2002-06-28
PT1325001E (en)	2004-07-30
EP1325001B1 (en)	2004-02-18
SK4352003A3 (en)	2003-08-05
HK1060566A1 (en)	2004-08-13
BR0114635A (en)	2004-02-10
CA2425557C (en)	2007-11-13
CN1275962C (en)	2006-09-20
MXPA03003160A (en)	2005-09-09
BG66225B1 (en)	2012-06-29
NO20031693L (en)	2003-05-28
ECSP034542A (en)	2003-06-25
CA2425557A1 (en)	2003-04-11
NZ525836A (en)	2004-09-24
YU29503A (en)	2006-03-03
RS50464B (en)	2010-03-02
SK287138B6 (en)	2010-01-07
EP1382606A3 (en)	2004-10-13
ATE259805T1 (en)	2004-03-15
PL360673A1 (en)	2004-09-20
IL155334A0 (en)	2003-11-23
EA200300459A1 (en)	2003-10-30
AR035589A1 (en)	2004-06-16
TR200400376T4 (en)	2004-03-22
EE05179B1 (en)	2009-06-15
ZA200302914B (en)	2003-11-14
JP4109106B2 (en)	2008-07-02
WO2002032899A1 (en)	2002-04-25
EA005816B1 (en)	2005-06-30
KR100830359B1 (en)	2008-05-20
CN1468236A (en)	2004-01-14
HRP20030278A2 (en)	2005-02-28
TWI306098B (en)	2009-02-11
PL207311B1 (en)	2010-11-30
MY127144A (en)	2006-11-30
EP1325001A1 (en)	2003-07-09
SA01220414B1 (en)	2007-01-20
HUP0301203A3 (en)	2006-05-29
ES2215147T3 (en)	2004-10-01
AU2002213975B2 (en)	2006-11-09
MEP39908A (en)	2011-02-10
KR20030041165A (en)	2003-05-23
DE50101524D1 (en)	2004-03-25
BG107688A (en)	2003-09-30
JP2004511557A (en)	2004-04-15
SI1325001T1 (en)	2004-08-31
DK1325001T3 (en)	2004-06-21
IL155334A (en)	2009-02-11
EP1382606A2 (en)	2004-01-21
NO328207B1 (en)	2010-01-11
UY26958A1 (en)	2002-06-20
HUP0301203A2 (en)	2003-10-28
UA73804C2 (en)	2005-09-15
NO20031693D0 (en)	2003-04-11
DE10050994A1 (en)	2002-04-18
JP2008120834A (en)	2008-05-29
AU1397502A (en)	2002-04-29
HRP20030278B1 (en)	2006-02-28

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2014-06-16	MM4A	Lapsed by not paying the annual fees	Effective date: 20130928

Publication	Publication Date	Title
EE200300151A (en)	2003-06-16	Anticholinergics used as medicaments and methods for their preparation
PL401469A1 (en)	2013-02-04	Azabicyclic derivative, method of its production, its use in medicine and derivative composition
EE200200704A (en)	2004-08-16	New compounds, process for their preparation and their use
EE200200470A (en)	2003-12-15	New compounds, process for their preparation and their use
EE05223B1 (en)	2009-10-15	Triazolop rimidine compounds, process for their preparation and their use
CY2013011I2 (en)	2015-08-05	METHOD OF ADMINISTRATION OF DIPHOSPHONICS
EE200300544A (en)	2004-02-16	4-Anilinoquinoline-3-carboxamides, their use and preparation
DE60201475D1 (en)	2004-11-11	Polyhydroxyalkanoate-coated liposome and process for its preparation
NO20025450L (en)	2002-11-14	New pharmaceutical composition
EE200300145A (en)	2003-06-16	Aza and polyazanaphthalenylcarboxamides and pharmaceutical composition
PT1296974E (en)	2009-11-03	2-cyanopyrrolidine derivatives and their use as medicaments
CY2007029I1 (en)	2009-11-04	METHOD FOR THE PREPARATION OF SUBSTITUTED OCTANOYL-AMIDES
EE200300207A (en)	2003-08-15	Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition
HK1055739A1 (en)	2004-01-21	Novel quinuclidine derivatives and medicinal compositions containing the same
EE05149B1 (en)	2009-04-15	Biar acarboxamides, process for their preparation, pharmaceutical composition containing them and their use in therapy
ATE540013T1 (en)	2012-01-15	NAPHTHALINE DERIVATIVES
DK1524266T3 (en)	2007-06-25	Pharmaceutical composition
DE60132108D1 (en)	2008-02-07	FREEZER-DRIED PANTOPRAZOLE PREPARATION AND PANTOPRAZOLE INJECTION
IL153864A0 (en)	2003-07-31	Cyclic polyamine compounds and methods for the preparation thereof
LV12624A (en)	2001-03-20	Thienylazolylalcoxyethanamines their preparation and their application as medicaments
EE04490B1 (en)	2005-06-15	The compound, its method of preparation and its use in medicine
EE05020B1 (en)	2008-06-16	The pharmaceutical composition of G1buride
EE05308B1 (en)	2010-06-15	Process for the preparation of sulfonamide-substituted imidazotriazinones
EE200200697A (en)	2004-08-16	New compounds, process for their preparation and their use
DE60142051D1 (en)	2010-06-17	PREPARATION OF PERFLUOROLEFINES